LifeVantage Corporation (LFVN)
NASDAQ: LFVN
· Real-Time Price · USD
12.08
0.22 (1.85%)
At close: May 13, 2025, 3:59 PM
11.97
-0.91%
Pre-market: May 14, 2025, 08:00 AM EDT
LifeVantage Revenue Breakdown
| Period Ending | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 | Jun 30, 2019 | Jun 30, 2018 | Jun 30, 2017 | Jun 30, 2016 | Jun 30, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| LifeVantage TrueScience Skin Care Regimen Revenue | 56.25M | 49.49M | 22.88M | 22.62M | 23.74M | 20.88M | 21.66M | 24.44M | 32.91M | 38.29M |
| LifeVantage TrueScience Skin Care Regimen Revenue Growth | +13.65% | +116.35% | +1.15% | -4.73% | +13.69% | -3.62% | -11.35% | -25.75% | -14.03% | n/a |
| Product and Service, Other Revenue | 39.78M | 44.18M | 47.87M | 47.29M | 52.84M | 49.58M | 133.92M | 130.87M | 128.02M | 120.97M |
| Product and Service, Other Revenue Growth | -9.97% | -7.69% | +1.22% | -10.50% | +6.58% | -62.98% | +2.33% | +2.23% | +5.83% | n/a |
| Protandim Revenue | 104.14M | 119.72M | 135.62M | 150.27M | 156.34M | 155.5M | n/a | n/a | n/a | n/a |
| Protandim Revenue Growth | -13.02% | -11.72% | -9.75% | -3.88% | +0.54% | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 17.07M | 18.61M | 35.15M | 36M | 35.94M | 41.82M | 40.44M | 40.55M | 41.52M | 43.14M | 40.54M | 40.12M | 38.52M | 42.87M | 39.18M | 38.41M | 40.66M | 43.37M | 41.93M | 43.71M | 43.95M | 47.37M | 44.46M | 40.79M | 44.5M | 47.79M | 45.09M | 41.66M | 39.34M | 38.04M | 38.99M | 40.21M | 36.55M | 40.75M | 44.08M | 39.55M | 42.81M | 41.12M | 35.71M | 36.45M | 36.12M |
| Selling, General, and Administrative Revenue Growth | -8.32% | -47.05% | -2.35% | +0.17% | -14.06% | +3.42% | -0.28% | -2.35% | -3.74% | +6.40% | +1.06% | +4.14% | -10.14% | +9.42% | +2.00% | -5.53% | -6.24% | +3.43% | -4.07% | -0.54% | -7.21% | +6.54% | +8.99% | -8.34% | -6.89% | +6.00% | +8.22% | +5.90% | +3.43% | -2.44% | -3.03% | +10.01% | -10.30% | -7.55% | +11.44% | -7.62% | +4.12% | +15.17% | -2.04% | +0.92% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | 500K | 200K | 100K | 200K | 200K | 200K | 200K | 100K | 100K | 100K | 200K | 200K | 100K | 200K | 200K | 200K | 100K | 200K | 300K | 200K | 100K | 100K | 500K | 400K | 400K | 300K | 300K | 300K | 300K | 200K | 300K | 300K | 1.5M | 200K | 300K | 200K | 600K | 600K |
| Research and Development Revenue Growth | n/a | n/a | -100.00% | +150.00% | +100.00% | -50.00% | 0.00% | 0.00% | 0.00% | +100.00% | 0.00% | 0.00% | -50.00% | 0.00% | +100.00% | -50.00% | 0.00% | 0.00% | +100.00% | -50.00% | -33.33% | +50.00% | +100.00% | 0.00% | -80.00% | +25.00% | 0.00% | +33.33% | 0.00% | 0.00% | 0.00% | +50.00% | -33.33% | 0.00% | -80.00% | +650.00% | -33.33% | +50.00% | -66.67% | 0.00% | n/a |